Effect of microRNA-21 blockade in human triple negative breast cancer allografts on progression and immune checkpoint proteins

被引:0
|
作者
Jin, Yuan-Yuan
Desai, Vilas Shivaji
Castro, Miguel M.
Mitchell, Edith P.
Wickstrom, Eric
机构
[1] Bound Therapeut LLC, Cherry Hill, NJ USA
[2] Thomas Jefferson Univ, Philadelphia, PA USA
[3] Biosynthesis Inc, Lewisville, TX USA
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA
[5] Sidney Kimmel Canc Ctr, Philadelphia, PA USA
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13097
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Where do the immune checkpoint inhibitors stand in the management of triple negative breast cancer?
    El Rassy, Elie
    El Karak, Fadi
    Ghosn, Marwan
    IMMUNOTHERAPY, 2018, 10 (04) : 247 - 250
  • [42] Effect of simvastatin and microRNA-21 inhibitor on metastasis and progression of human salivary adenoid cystic carcinoma
    Wang, Chao
    Li, Ting
    Yan, Fei
    Cai, Wenyan
    Zheng, Jiwei
    Jiang, Xingyu
    Sun, Jinhu
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 : 1054 - 1061
  • [43] LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
    Iván Pérez-Núñez
    Catalina Rozalén
    José Ángel Palomeque
    Irene Sangrador
    Mariona Dalmau
    Laura Comerma
    Anna Hernández-Prat
    David Casadevall
    Silvia Menendez
    Daniel Dan Liu
    Minhong Shen
    Jordi Berenguer
    Irene Rius Ruiz
    Raul Peña
    José Carlos Montañés
    M. Mar Albà
    Sarah Bonnin
    Julia Ponomarenko
    Roger R. Gomis
    Juan Miguel Cejalvo
    Sonia Servitja
    Diego M. Marzese
    Lluis Morey
    Leonie Voorwerk
    Joaquín Arribas
    Begoña Bermejo
    Marleen Kok
    Lajos Pusztai
    Yibin Kang
    Joan Albanell
    Toni Celià-Terrassa
    Nature Cancer, 2022, 3 : 355 - 370
  • [44] Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
    Palakurthi, Bhavana
    Fross, Shaneann R.
    Guldner, Ian H.
    Aleksandrovic, Emilija
    Liu, Xiyu
    Martino, Anna K.
    Wang, Qingfei
    Neff, Ryan A.
    Golomb, Samantha M.
    Lewis, Cheryl
    Peng, Yan
    Howe, Erin N.
    Zhang, Siyuan
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [45] Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
    Bhavana Palakurthi
    Shaneann R. Fross
    Ian H. Guldner
    Emilija Aleksandrovic
    Xiyu Liu
    Anna K. Martino
    Qingfei Wang
    Ryan A. Neff
    Samantha M. Golomb
    Cheryl Lewis
    Yan Peng
    Erin N. Howe
    Siyuan Zhang
    Nature Communications, 14
  • [46] LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
    Perez-Nunez, Ivan
    Rozalen, Catalina
    Angel Palomeque, Jose
    Sangrador, Irene
    Dalmau, Mariona
    Comerma, Laura
    Hernandez-Prat, Anna
    Casadevall, David
    Menendez, Silvia
    Dan Liu, Daniel
    Shen, Minhong
    Berenguer, Jordi
    Ruiz, Irene Rius
    Pena, Raul
    Carlos Montanes, Jose
    Alba, M. Mar
    Bonnin, Sarah
    Ponomarenko, Julia
    Gomis, Roger R.
    Miguel Cejalvo, Juan
    Servitja, Sonia
    Marzese, Diego M.
    Morey, Lluis
    Voorwerk, Leonie
    Arribas, Joaquin
    Bermejo, Begona
    Kok, Marleen
    Pusztai, Lajos
    Kang, Yibin
    Albanell, Joan
    Celia-Terrassa, Toni
    NATURE CANCER, 2022, 3 (03) : 355 - +
  • [47] Effective inhibition of metastasis in triple-negative breast cancer (TNBC) mouse model by combining immunogenic chemotherapy and immune checkpoint blockade
    Yuan, Xiangliang
    Xiao, Yi
    Liu, Xianghua
    Kuo, Wenling
    Li, Hongzhong
    Li, Ping
    Yagita, Hideo
    Yu, Dihua
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Targeting CXCL12-CXCR4 Signaling Enhances Immune Checkpoint Blockade Therapy Against Triple Negative Breast Cancer
    Lu, Guowen
    Qiu, Yier
    Su, Xiaobao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 157
  • [49] Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy
    Wang, Zhiren
    Cordova, Leyla Estrella
    Chalasani, Pavani
    Lu, Jianqin
    MOLECULAR PHARMACEUTICS, 2022, 19 (12) : 4665 - 4674
  • [50] Phenotypes and cytokines of NK cells in triple-negative breast cancer resistant to checkpoint blockade immunotherapy
    Youlong Wang
    Yongluo Jiang
    Fadian Ding
    Jun Lu
    Tong Huang
    Guanqing Zhong
    Pengfei Zhu
    Yue Ma
    Jin Li
    Xinjia Wang
    Jiacai Lin
    Hongjun Zheng
    Weidong Wang
    Yiwei Xu
    Xiajie Lyu
    Yu Si Niu
    Xin Qi
    Jinjian Li
    Bocen Chen
    Tingting He
    Jiling Zeng
    Yifei Ma
    Breast Cancer Research, 27 (1)